Literature DB >> 2393342

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.

C Benkelfat1, T E Nordahl, W E Semple, A C King, D L Murphy, R M Cohen.   

Abstract

In a recent study, we reported abnormal local cerebral glucose metabolic rates in the orbital frontal cortex of patients with obsessive-compulsive disorder. Eight patients with obsessive-compulsive disorder scanned previously were scanned again during treatment with the tricyclic antidepressant clomipramine hydrochloride. Comparisons of local cerebral glucose metabolic rates for both groups showed a relative decrease in regions of the orbital frontal cortex and the left caudate, and an increase in other areas of the basal ganglia, including the right anterior putamen. When comparing patients who responded well to clomipramine with those who were either poor or partial responders, we found significant decreases only in the left caudate of patients who responded well to the drug. The present study suggests that clomipramine-induced improvement in obsessive-compulsive symptoms is associated with a return of regional brain metabolism to a more normal level in regions of the orbital frontal cortex and the caudate nucleus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393342     DOI: 10.1001/archpsyc.1990.01810210048007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  44 in total

1.  Comorbidities of obsessive and compulsive symptoms in Huntington's disease.

Authors:  Karen E Anderson; Carissa R Gehl; Karen S Marder; Leigh J Beglinger; Jane S Paulsen
Journal:  J Nerv Ment Dis       Date:  2010-05       Impact factor: 2.254

2.  Lateral orbitofrontal dysfunction in the Sapap3 knockout mouse model of obsessive–compulsive disorder

Authors:  Huimeng Lei; Juan Lai; Xiaohong Sun; Qunyuan Xu; Guoping Feng
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

3.  Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.

Authors:  Nancy A Shanahan; Lady P Velez; Virginia L Masten; Stephanie C Dulawa
Journal:  Biol Psychiatry       Date:  2011-09-13       Impact factor: 13.382

4.  Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene.

Authors:  Andrea Calvo; Cristina Moglia; Antonio Canosa; Angelina Cistaro; Consuelo Valentini; Giovanna Carrara; Enzo Soldano; Antonio Ilardi; Enrica Bersano; Davide Bertuzzo; Maura Brunetti; Irene Ossola; Gabriella Restagno; Adriano Chiò
Journal:  J Neurol       Date:  2012-08-24       Impact factor: 4.849

5.  Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder.

Authors:  Edoardo F Q Vattimo; Vivian B Barros; Guaraci Requena; João R Sato; Daniel Fatori; Euripedes C Miguel; Roseli G Shavitt; Marcelo Q Hoexter; Marcelo C Batistuzzo
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-04-10       Impact factor: 4.785

6.  Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.

Authors:  Chan-Hyung Kim; Min-Seong Koo; Keun-Ah Cheon; Young-Hoon Ryu; Jong-Doo Lee; Hong-Shick Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-25       Impact factor: 9.236

Review 7.  Annual research review: Current limitations and future directions in MRI studies of child- and adult-onset developmental psychopathologies.

Authors:  Guillermo Horga; Tejal Kaur; Bradley S Peterson
Journal:  J Child Psychol Psychiatry       Date:  2014-01-20       Impact factor: 8.982

8.  Cerebral blood flow and metabolism in anxiety and anxiety disorders.

Authors:  R J Mathew
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

9.  The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system.

Authors:  Eduardo A Schilman; Oded Klavir; Christine Winter; Reinhard Sohr; Daphna Joel
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.